[1]
Karupiah, M.K. et al. 2021. THE EFFECT OF LUSEOGLIFLOZIN ON CARDIOMETABOLIC MARKERS IN PATIENTS WITH PREDIABETES (IMPAIRED GLUCOSE TOLERANCE): A PILOT STUDY. Journal of the ASEAN Federation of Endocrine Societies. 36, (Jul. 2021), 13. DOI:https://doi.org/10.15605/jafes.036.S13.